SCI & TECH● LOWAug 3 · Aug 3, 2026, 1:28 PM
Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
Seeking Alpha Tech
Zai Lab has been granted Orphan Drug status for its ADC, a drug intended for neuroendocrine carcinomas. This designation is a key step in the development of treatments for rare diseases.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH27m agoTowering glacial ice cliffs may collapse in fits and startsNew ScientistSCI & TECH27m agoGoogle showcases way to fix quantum computer errors more efficientlyNew ScientistSCI & TECH34m agoAnthropic grants employee-level access to nonprofit AI evaluator METRSeeking Alpha TechSCI & TECH36m agoExperts discuss roadmap for quantum-resistant digital infrastructureThe Hindu